Supplementary Figure S6 from Clinical and molecular features of long-term response to immune checkpoint inhibitors in patients with advanced non-small cell lung cancer

Rohit Thummalapalli; Biagio Ricciuti; Chaitanya Bandlamudi; Daniel M. Muldoon; Hira Rizvi; Arielle Elkrief; Jia Luo; Joao V. Alessi; Federica Pecci; Giuseppe Lamberti; Alessandro Di Federico; Lingzhi Hong; Jianjun Zhang; John V. Heymach; Don L. Gibbons; Andrew J. Plodkowski; Vignesh Ravichandran; Mark T.A. Donoghue; Chad Vanderbilt; Marc Ladanyi; Charles M. Rudin; Mark G. Kris; Gregory J. Riely; Jamie E. Chaft; Matthew D. Hellmann; Natalie I. Vokes; Mark M. Awad; Adam J. Schoenfeld

doi:10.1158/1078-0432.27033028.v1

Abstract

This is the authors' abstract. We don't add key points for this paper.

Univariable analyses of association of clinical characteristics with long-term response (LTR) compared to short-term response (STR), non-LTR, and progressive disease (PD).

Ask about this paper

Answers are grounded in this paper and cite their sources.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Thummalapalli et al. (2024) studied this question.

synapsesocial.com/papers/68e58589b6db643587522791 https://doi.org/10.1158/1078-0432.27033028.v1

View at Publisher

Ask AI

Bookmark

Share

Supplementary Figure S6 from Clinical and molecular features of long-term response to immune checkpoint inhibitors in patients with advanced non-small cell lung cancer

Abstract

Ask about this paper

Discussion

Cite This Study

Supplementary Figure S6 from Clinical and molecular features of long-term response to immune checkpoint inhibitors in patients with advanced non-small cell lung cancer

Abstract

Ask about this paper

Discussion

Cite This Study

Keep reading

Keep reading